Abstract |
Hypoxic-ischemic brain injury is regulated in part by neurotransmitter and chemokine signaling via G-protein-coupled receptors (GPCRs). GPCR- kinase 2 (GRK2) protects these receptors against overstimulation by inducing desensitization. Neonatal hypoxic-ischemic brain damage is preceded by a reduction in cerebral GRK2 expression. We determined the functional importance of GRK2 in hypoxic-ischemic brain damage. Nine-day-old wild-type and GRK2(+/-) mice with a approximately 50% reduction in GRK2 protein were exposed to unilateral carotid artery occlusion and hypoxia. In GRK2(+/-) animals, gray and white matter damage was aggravated at 3 weeks after hypoxia- ischemia. In addition, cerebral neutrophil infiltration was increased in GRK2(+/-) animals. Neutrophil depletion reduced brain damage, but neuronal loss was still more pronounced in GRK2(+/-) animals. Onset of neuronal loss was advanced in GRK2(+/-) animals regardless of neutrophil depletion. White matter injury was advanced in GRK2(+/-) animals and was not affected by neutrophil depletion. Activation/infiltration of microglia/macrophages was stronger in GRK2(+/-) brains but only occurred 24 h after hypoxia- ischemia and is therefore not the primary cause of increased damage. During hypoxia, cerebral blood flow was reduced to the same extent in both genotypes. In vitro, GRK2(+/-) hippocampal slices and cerebellar granular neurons were more sensitive to glutamate-induced death. We propose the novel concept that the kinase GRK2 regulates onset and magnitude of hypoxic-ischemic brain damage. Increased gray and white matter damage in GRK2(+/-) animals was not dependent on infiltrating neutrophils and occurred before microglia/macrophage activation was detected. Collectively, our data suggest that cerebral GRK2 has an important endogenous neuroprotective role in ischemic cerebral damage.
|
Authors | Cora H A Nijboer, Annemieke Kavelaars, Anne Vroon, Floris Groenendaal, Frank van Bel, Cobi J Heijnen |
Journal | The Journal of neuroscience : the official journal of the Society for Neuroscience
(J Neurosci)
Vol. 28
Issue 13
Pg. 3324-32
(Mar 26 2008)
ISSN: 1529-2401 [Electronic] United States |
PMID | 18367599
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, CD
- Antigens, Differentiation, Myelomonocytic
- CD68 antigen, human
- Myelin Basic Protein
- Glutamic Acid
- Peroxidase
- GRK2 protein, mouse
- G-Protein-Coupled Receptor Kinase 2
|
Topics |
- Animals
- Animals, Newborn
- Antigens, CD
(metabolism)
- Antigens, Differentiation, Myelomonocytic
(metabolism)
- Apoptosis
- Brain Injuries
(etiology, pathology)
- G-Protein-Coupled Receptor Kinase 2
(deficiency, metabolism)
- Gene Expression Regulation, Developmental
(drug effects, physiology)
- Glutamic Acid
(toxicity)
- Hypoxia-Ischemia, Brain
(complications)
- In Vitro Techniques
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Myelin Basic Protein
(metabolism)
- Neuroglia
(drug effects, metabolism)
- Neurons
(drug effects, metabolism)
- Neutrophil Infiltration
(physiology)
- Peroxidase
(metabolism)
- Regional Blood Flow
(physiology)
- Subcellular Fractions
(metabolism)
- Time Factors
|